Clinical trial
Endoscopic Implantation of Enteryx for the Treatment of GERD
NCT00346905 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00346905 |
|---|---|
| Title | Endoscopic Implantation of Enteryx for the Treatment of GERD |
| Official title | Endoscopic Implantation of Enteryx for the Treatment of Gastroesophageal Reflux Disease (GERD): Post Market Study |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux |
| Intervention type | Drug |
| Interventions | Enteryx |
| Enrollment | 16 |
| Start date | Oct 1, 2003 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Jun 30, 2006 |
| Last update posted | Jul 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: